Skip to content

Company Information

Napp Pharmaceutical Holdings Limited is a company registered in England & Wales with company number 03486244. Service provider: napp.test is the domain name of Napp Pharmaceutical Holdings Limited. Email address of server: enquiries@napp.co.uk Registered Office: Cambridge Science Park, Milton Road, Cambridge, CB4 0GW, tel: +44 (0) 1223 424 444, fax: +44 (0) 1223 424 441, www.napp.co.uk VAT Number: 197026251

Napp Pharmaceuticals Limited is a company registered in England & Wales with company number 03690299. Service Provider: napp.test is the domain name of Napp Pharmaceuticals Limited. Email address of server: enquiries@napp.co.uk Registered Office: Cambridge Science Park, Milton Road, Cambridge, CB4 0GW, tel: +44 (0) 1223 424 444, fax: +44 (0) 1223 424 441, www.napp.co.uk VAT Number: 197026251

Bard Pharmaceuticals Limited is a company registered in England & Wales with company number 00987562. Service Provider: napp.test is the domain name of Bard Pharmaceuticals Limited. Email address of server: enquiries@napp.co.uk Registered Office: Cambridge Science Park, Milton Road, Cambridge, CB4 0GW, tel: +44 (0) 1223 424 444, fax: +44 (0) 1223 424 441, www.napp.co.uk VAT Number: 197026251

Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”